Top Institutions in Ophthalmology
Institutions were ranked based on their known expertise in retinal diseases, particularly AMD and GA, their leadership in clinical trials for novel GA therapies, and their contributions to coding, billing, and healthcare policy related to ophthalmic treatments.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with extensive research and clinical trials in AMD and GA treatments, including leadership in novel drug therapies and their implementation.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear has a strong reputation for retinal disease research, including AMD and GA, with significant contributions to clinical trials and health policy guidance on treatment reimbursement.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its research in retinal degenerative diseases and its role in shaping clinical protocols and reimbursement policies for new ophthalmic treatments.
Key Differentiators
- Ophthalmology
- Retina
- Health Policy
-
#4
University of California San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in retinal disease research and clinical trials, with expertise in implementing new treatment protocols and navigating complex billing environments for GA therapies.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#5
Mayo Clinic
Rochester, MN
Mayo Clinic has a comprehensive ophthalmology program with a focus on retinal diseases and is involved in clinical trials and policy development related to GA treatment reimbursement.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


